Protection Against Chemotherapy-Induced Alopecia
Authors:
- 14 September 2006
- journal article
- review article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 23 (11) , 2505-2514
Abstract
The goal is to provide an overview on the advances in protection against chemotherapy-induced alopecia (CIA).Keywords
This publication has 110 references indexed in Scilit:
- Stem cells in the skin: waste not, Wnt notGenes & Development, 2003
- Efficacy and tolerance of a scalp-cooling system for prevention of hair loss and the experience of breast cancer patients treated by adjuvant chemotherapySupportive Care in Cancer, 2002
- Morphogenesis and Renewal of Hair Follicles from Adult Multipotent Stem CellsCell, 2001
- 1,25(OH)2Vitamin D3Induces Elevated Expression of the Cell Cycle-regulating Genes P21 and P27 in Squamous Carcinoma Cell Lines of the Head and NeckActa Oto-Laryngologica, 2001
- Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapySupportive Care in Cancer, 1997
- Changes in self-concept and body image during alopecia induced cancer chemotherapySupportive Care in Cancer, 1997
- A randomized trial of minoxidil in chemotherapy-induced alopeciaJournal of the American Academy of Dermatology, 1996
- Pretreatment With 1,25(OH)2D3 Protects From Cytoxan-Induced Alopecia Without Protecting the Leukemic Cells From CytoxanThe American Journal of the Medical Sciences, 1995
- Growth Inhibition of Human Keratinocytes by 1,25-Dihydroxyvitamin D3 Is Linked to Dephosphorylation of Retinoblastoma Gene ProductBiochemical and Biophysical Research Communications, 1993
- The secret life of the hair follicleTrends in Genetics, 1992